Valuation Biosynex

Stocks

Real-time Euronext Paris Other stock markets 17:24:37 31/07/2026 +03			5-day change	1st Jan Change
0.9200 ^EUR	+1.77%		0.00%	+54.36%

06-11	Triple update for Biosynex
06-11	An undisclosed buyer acquired Entire internal molecular biology business from Biosynex SA for ?4 million.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	151.6	289.9	141	85.85	18.51	11.17
Change	-	91.16%	-51.35%	-39.13%	-78.44%	-39.63%
Enterprise Value (EV) ¹	130.6	193.2	105.9	125.7	71.44	64.36
Change	-	47.93%	-45.16%	18.6%	-43.14%	-9.91%
P/E	5.44x	2.63x	9.08x	-2.42x	-0.43x	-0.19x
PBR	2.29x	1.62x	0.87x	0.72x	0.23x	0.3x
PEG	-	0x	-0.1x	0x	-0x	0x
Capitalization / Revenue	0.99x	0.76x	0.72x	0.92x	0.18x	0.12x
EV / Revenue	0.85x	0.5x	0.54x	1.35x	0.71x	0.68x
EV / EBITDA	2.84x	1.36x	2.28x	-4.21x	-3.22x	-4.72x
EV / EBIT	2.86x	1.37x	2.72x	-3.48x	-2.59x	-2.47x
EV / FCF	7.61x	2.62x	-3.59x	-2.83x	-43.6x	4.54x
FCF Yield	13.1%	38.1%	-27.9%	-35.3%	-2.29%	22%
Dividend per Share ²	0.2	2	-	-	-	-
Rate of return	1.2%	7.6%	-	-	-	-
EPS ²	3.05	10.01	1.52	-3.45	-4.03	-3.159
Distribution rate	6.56%	20%	-	-	-	-
Net sales ¹	153.9	382.5	196.6	92.98	101.2	95.19
EBITDA ¹	46.02	141.8	46.49	-29.82	-22.16	-13.64
EBIT ¹	45.73	140.7	38.88	-36.15	-27.53	-26.05
Net income ¹	31.37	104	15.66	-36.95	-43.33	-58.22
Net Debt ¹	-21.07	-96.72	-35.09	39.8	52.94	53.19
Reference price ²	16.6000	26.3200	13.8000	8.3500	1.7200	0.5960
Nbr of stocks (in thousands)	9,135	11,014	10,220	10,281	10,761	18,748
Announcement Date	4/21/21 A	4/25/22 A	4/28/23 A	4/30/24 A	4/30/25 A	5/7/26 A

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BIOSYNEX	-	-	-	-	19.18M
GUARDANT HEALTH, INC.	-52.56x	15.83x	-115.88x	-.--%	20.2B
BIOMÉRIEUX	17.59x	1.96x	8.27x	1.45%	9.76B
LANTHEUS HOLDINGS, INC.	22.82x	4.28x	12.13x	-	6.58B
10X GENOMICS, INC.	-60.93x	9.44x	-80.36x	-.--%	6.28B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	20.96x	7.21x	16.29x	2.75%	5.66B
CARIS LIFE SCIENCES, INC.	163.73x	4.09x	26.75x	-.--%	4.55B
DIASORIN S.P.A.	19.9x	3.52x	10.95x	1.9%	4.21B
AUTOBIO DIAGNOSTICS CO., LTD.	16.79x	-	-	3.82%	2.83B
Average	18.54x	6.62x	-17.41x	1.42%	6.68B
Weighted average by Cap.	-2.13x	8.75x	-42.37x	0.91%